(or what) are AHVLA? - MERIAL Avian Forum 2013
Transcription
(or what) are AHVLA? - MERIAL Avian Forum 2013
Merial Avian Forum 2013 Istanbul, Turkey 17 – 19 April 2013 Richard Irvine BVetMed MSc(CIDA) MRCVS Deputy Head, Avian Virology & Mammalian Influenza Group EU/OIE/FAO International Reference Laboratory for AI & ND AHVLA‐Weybridge Chair, AHVLA/SRUC Avian Expert Group Vice‐chair NFU Poultry Health Group Richard.Irvine@ahvla.gsi.gov.uk Infectious Bronchitis Virus An evolving pathogen Introduction • AHVLA: roles • Infectious Bronchitis virus (IBV) overview – – – – Virus and disease Epidemiology and evolution Diagnosis Prevention and Control • Challenges • Concluding thoughts Who (or what) are AHVLA? • Animal Health and Veterinary Laboratories Agency • Executive agency of Defra (Great Britain) • Created from merger of the Veterinary Laboratories Agency (VLA) with Animal Health in April 2011 • National and International Reference Laboratory for a wide range of animal diseases, including: – OIE/EU/FAO International Reference Laboratory for Avian Influenza & Newcastle disease AHVLA: What do we do? • • • • • • Disease surveillance & investigation Laboratory diagnostics Fundamental and applied R&D Avian & mammalian Influenza Newcastle disease Emergency Disease Outbreak responses The AHVLA laboratory network provides local catchment areas for submission, investigation and testing of diagnostic samples and carcase post‐mortems Infectious Bronchitis Virus An evolving pathogen A veterinary perspective Virus biology • • • • • Group: IV (+)ssRNA Order: Nidovirales Family: Coronaviridae Subfamily: Coronavirinae Genus: Gammacoronavirus – Large RNA genome: 27.6kb – Surface Spike (S) protein – S1 subunit mediates • Virus attachment • Antigenicity • Immunogenicity Courtesy of Dave Everest, AHVLA Weybridge Gammacoronaviruses infect many different avian species… Sites of IBV replication Respiratory tract Kidneys Proventriculus Alimentary tract Oviduct Testes Clinical signs of IBV Snicking (sneezing), tracheal râles, nasal discharge Urates (wet litter) Poor feed intake & uneven birds Diarrhoea (wet litter) Decrease in egg production & egg quality in hens False layer syndrome Enlarged kidneys due to infection with a nephropathogenic IBV strain Images: AHVLA Relevance of IBV: Poultry (1) • 1930s: first demonstration of disease caused by coronavirus was IBV in domestic fowl in the USA – Massachusetts (Mass) serotype • 1950s: Connecticut (Conn) variant strains in USA – Non‐Mass variants since identified from 1940s in USA – Mass serotype strains in Latin America • Development of live Mass‐type IBV vaccines – International spread of Mass serotype IBV with poultry • 1970s onwards: Reported emergence and evolution of other IBV variants around the world Relevance of IBV: Poultry (2) • Global distribution of many different IBV serotypes – Variation within and between countries and regions – Indigenous IBV variants in many regions • IBV is of major economic, health and welfare importance to poultry & poultry industry worldwide • Continued emergence and evolutionary divergence of IBV variants – Changes in Spike (S) protein amino acids – Novel variants do not always persist & spread, but some do, causing major disease and control challenges Global Distributions of IBV, 1950‐ IBV Serotypes identified Europe Asia Americas Australia Mass D207 D212 D3128 D3896 D1466 PL‐64084‐France A224.74/Italy B1648‐Belgium UK/918/67 UK6/82 UK/142/86 UK793/B 624/Italy QX (D388) Mass Conn Gray Ark 99 N1/52‐T Kb8523‐Japan 793/B‐India NRZ‐China HV‐China SAIB3‐China KM91‐Korea EJ95‐Korea A1121‐Taiwan QX Mass Conn Florida Clark 333 Ark 99 SE17 JMK Iowa 97 Iowa 609 Holte Gray Main 209 DE/072/92 Chile 14 50/96‐Brazil 22/97‐Honduras A‐Vac1 B‐Vic S C‐N1/62 D‐N9/74 E‐01/73 F‐V2/71 G‐V1/71 H‐N1/75 I‐N2/75 J‐N3/63 K‐T1/82 L‐N1/88 M‐03/88 0‐NT2/89 P‐N1/81 Q‐V18/91 Adapted from: Ignjatovic, J. & Sapats, S. (2000) Avian Infectious Bronchitis virus. Rev. Sci. Tech. Off. int. Epiz.,19 2, pp. 493‐508. Data also from: de Wit et al (2010) Infectious bronchitis virus in Asia, Africa, Australia and Latin America ‐ history, current situation and control measures. Rev. Bras. Cienc. Avic. 12(2),pp.97‐106; de Wit et al (2011) Infectious bronchitis virus variants: a review of the history, current situation and control measures. Avian Pathology, 40(3),pp.223‐235; Jackwood, M. (2012) Review of Infectious Bronchitis Around the World. Avian Diseases, 56,pp.634‐641. Global Distribution & Diversity of IBV de Wit, J.J. et al (2011) Infectious bronchitis virus variants: a review of the history, current situation and control measures Avian Pathology, 40(3),pp.223‐235 Contemporary IBV genotypes in Western Europe (2002‐2006) Worthington et al (2008) A reverse transcriptase‐polymerase chain reaction survey of infectious bronchitis virus genotypes in Western Europe from 2002 to 2006, Avian Pathology,37:3,pp.247‐257 The emergence and evolution of IBV variants can occur by: ‐ Mutation ‐ Recombination Shu‐Ming, K. et al (2013) Evolution of infectious bronchitis virus in Taiwan: Positively selected sites in the nucleocapsid protein and their effects on RNA‐binding activity. Vet Micro, 162(2), pp.408‐418. IBV variants have different properties Mutation Recombination IBV variants Variations in phenotype & genotype Virus Antigenicity Vaccinal & host responses interactions Virulence Clinical signs Tissue tropism Pathology After: Montassier, H.J. (2010) Molecular Epidemiology and Evolution of Avian Infectious Bronchitis Virus. Rev. Bras. Cienc. Avic. [online] 12(2)pp.87‐96 Diagnosis of IBV: Field • • • • • Observed clinical signs and history Flock production type, targets and records Vaccination and flock husbandry conditions Veterinary investigation ‐ site visit Clinical signs and gross pathology can be similar to those caused by other diseases, including AI & ND – Consideration of differential diagnoses is essential! • Flock sampling – Swab & blood samples • Post‐mortem examination – Batch of affected birds/culls Laboratory methods (1) • Virus isolation • Serology – ELISA – HIT – AGP, VNT • Electron microscopy • Molecular methods ‐ PCR • S1 gene sequencing AHVLA Weybridge Laboratory methods (2) • Virus isolation: live virus Costly, takes time • Serology: antibody detection Need serial samples – ELISA – HIT – AGP, VNT Diagnosis & monitoring Interpretation of results complicated by use of IBV vaccines • Electron microscopy Insensitive, costly • Molecular methods: viral RNA • S1 sequencing: IBV genotypes Rapid, sensitive, specific and cost‐effective Day 0: Samples received ≤ 7 days: IBV PCR positive ≤ 14 days: IBV genotype result 7 days: Egg passage (EP) 1 21 days: Negative – EP3 Suspect IBV for typing 28 days: Negative – VI complete Suspect IBV for typing Diagnosis of IBV: Lab • AHVLA has developed and validated a real‐time RT‐PCR and partial S1 sequencing method • Supports timely disease prevention and control decision‐ making, including IBV vaccination Nucleic acid extraction Real‐time RT‐PCR RRT‐PCR results Jones, R.M., et al (2011). Development and Validation of RT‐PCR Tests for the Detection and S1 Genotyping of Infectious Bronchitis Virus and other Closely Related Gammacoronaviruses within Clinical Samples. Transboundary and Emerging Diseases, 8(5), pp.411–420. Co‐circulation of IBV genotypes & H9 in Iraq • UNFAO and AHVLA • Clinical disease and high mortality in broiler flocks from seven regions of Iraq • European QX‐ and Variant 2 (US)‐like IBV genotypes Reid et al (2013) WPSA, Oral presentation Co‐circulation of IBV genotypes in UK • ~3,500 samples tested (PCR) • Non‐pooled & Pooled samples • Health problems in poultry flocks from across UK • Multiple genotypes circulating • Widespread live vaccine use Prevention of IBV • Biosecurity – Prevent introduction of all diseases, including IBV • Different serotypes of IBV do not cross‐protect • However, some IBV strains can induce cross‐protection against other serotypes • Live attenuated primer from day‐old (growers) • Inactivated (killed) booster (point‐of‐lay hens) Cross‐protection between IBV strains varies with S1 gene homology de Wit, J.J. et al (2011) Infectious bronchitis virus variants: a review of the history, current situation and control measures Avian Pathology, 40(3),pp.223‐235 Vaccines are an important tool • Mass‐type live attenuated vaccines – Good protection if Mass IBV serotype in‐region – Variable/poor protection if infection with heterologous variant IBV challenge (or other causes of disease!) • Use of two different serotypes of live IBV vaccine (eg. Mass + variant) can provide broader protection and efficacy against different IBV types – IBV ‘protectotypes’ so not always need new vaccine – Many and various ‘double live vaccine’ schedules • However, may not protect against all IBV variants Prevention & Control of IBV as a cause of flock health problems • Prompt veterinary investigation of flocks • Consider differential diagnoses and correct sampling • Robustly validated, appropriate & timely lab testing • Diagnostic information to inform disease prevention & control decision‐making – Appropriate vaccine selection – Correct vaccine handling, storage and administration • Biosecurity is good for your business • Surveillance – systematic (scanning vs. active) Global challenges faced • Livestock production & disease problems • Globalisation • Climate change • Population growth • Public health threats • Antimicrobial resistance “When all people at all times have access to sufficient, safe, nutritious food to maintain a healthy and active life” World Food Summit, 1996 Poultry value chains make safe, quality and nutritious food available for people worldwide Inputs and production efficiency gains from Vet & Ag Services Outline commercial broiler system value chain Some requirements to meet global poultry health challenges • Veterinary and public health disease surveillance • Disease awareness & knowledge transfer • Early reporting and investigation of disease problems • Rapid response and tools to detect & control disease • Supply chain infrastructure, integration & collaboration – Farmers, Industry, Pharma, Vets, Scientists, Labs • Strategic & multi‐disciplinary research Declare the past, diagnose the present, foretell the future Hippocrates, 400 BC Epidemics, Second Constitution, Book 1, Section XI Translated by WHS Jones Cambridge: Harvard University Press, 1995. BMJ (2002), 324:1448 Acknowledgements • Avian Virology & Mammalian Influenza Group, Weybridge – Ian Brown, Dennis Alexander, Ruth Manvell – Jill Banks, Sharon Brookes, Chad Fuller, Scott Reid & teams • • • • • • • • • Poultry Industry Poultry owners & keepers Private Veterinary Surgeons AHVLA Regional Laboratories & Field staff Defra EU OIE FAO Merial Thank you for your attention Richard.Irvine@ahvla.gsi.gov.uk